Posts classified under: Leadership of Sponsoring Institutes

Dr. Ali Mosleh is Distinguished Professor and holder of the Evalyn Knight Chair in Engineering at the University of California in Los Angeles. Prior to that he was the Nicole J. Kim Eminent Professor of Engineering and Director of the Center for Risk and Reliability at the University of Maryland. Dr. Mosleh is also a Fellow of the Society for Risk Analysis, and the American Nuclear Society, recipient of several scientific achievement awards, and consultant and technical advisor to numerous national and international organizations. In 2004 he was appointed by President George W. Bush to the U.S. Nuclear Waste Technical Review Board. He continued to serve on the board under President Obama until 2012.

Dr. Geschwind is the Gordon and Virginia MacDonald Distinguished Professor of Human Genetics, Neurology and Psychiatry at UCLA. In his capacity as Senior Associate Dean and Associate Vice Chancellor of Precision Health, he leads the Institute for Precision Health at UCLA. His laboratory has pioneered the application of systems biology methods in neurologic and psychiatric disease. Dr. Geschwind has put considerable effort into fostering large-scale collaborative patient resources for genetic research and data sharing in autism research. He has served on numerous scientific advisory boards, including the Faculty of 1000 Medicine, the Executive Committee of the American Neurological Association, the Scientific Advisory Board for the Allen Institute for Brain Science, the NIMH Advisory Council and the NIH Council of Councils. He has published over 400 papers and serves on the editorial boards of Cell, Neuron and Science. He has received several awards for his laboratory’s work and leadership including the Ruane Prize from the Brain and Behavior Foundation in 2013 and the Derek Denny-Brown Neurological Scholar Award from the American Neurological Association (ANA) in 2004. He is an elected member of the American Association of Physicians and the National Academy of Medicine.

Dr. Steven Dubinett is Associate Vice Chancellor for Research and Director of the JCCC Lung Cancer Research Program. He has extensive experience in translational investigation, academic administration, mentorship and peer review. He is Chief, Division of Pulmonary and Critical Care Medicine and jointly appointed as Professor in the Departments of Medicine, Pathology and Laboratory Medicine, and Molecular and Medical Pharmacology. He has served on national advisory panels and committees including the NCI’s Translational Research Working Group. He has experience directing large, multidisciplinary research teams funded by the NCI SPORE program, the Early Detection Research Network and the Department of Defense. He has served as a permanent member of three different NIH study sections and numerous Special Emphasis Panels. He has been consistently funded by peer-reviewed federal resources for translational research in lung cancer for more than 20 years. He served as a member of the FDA Cellular, Tissue and Gene Therapies Advisory Committee and on several editorial boards including Clinical and Translational Science. He is an Associate Editor in Chief of the American Journal of Translational Research.